Fundraising Fox

Matthew D. Ronsheim

Chief Operating Officer at Xenon Pharma

Greater Boston

Find your path to Matthew

198 people in our graph share verified history with Matthew — schools, employers, funds. One of them is your warm intro.

Vincent RoseunlockedMatthew: together at Bayer
×5Matthew: together at University of New Hampshire
×6Matthew: together at Bayer

Chief Operating Officer at Xenon Pharma

Intro paths

→

In turn, Matthew can intro founders to Xenon Pharma's investors below.

Xenon Pharma's investors · 3

Avoro Capital AdvisorsNew YorkForesite CapitalWest HollywoodNew Enterprise Associates (NEA)Menlo Park · $200K – $40M checks

Experience

  1. Xenon Pharmaceuticals Inc.Chief Operating Officercurrent2024 — presentBoston, MA
  2. Innoviva Specialty Therapeutics, Inc.President2024Waltham, Massachusetts, United States
  3. Innoviva Specialty Therapeutics, Inc.Chief Technical Officer2023 — 2024Waltham, Massachusetts, United States
  4. Entasis TherapeuticsPresident2022 — 2023Waltham, MA
  5. Entasis TherapeuticsChief Pharmaceutical Sciences & Manufacturing Officer2020 — 2022Waltham, Massachusetts, United States
  6. Entasis TherapeuticsVice President, CMC2019 — 2020
  7. Enanta PharmaceuticalsExecutive Director, Head of CMC2017 — 2019Greater Boston Area
  8. Enanta PharmaceuticalsSenior Director, Head of CMC2016 — 2017Greater Boston Area
  9. MerckDirector, Project Leadership/Global Pharmaceutical Commercialization2015 — 2016Greater Boston Area
  10. Cubist PharmaceuticalsDirector, CMC Project Management2014 — 2015Lexington, MA
  11. Forest Laboratories (now Allergan)Director, Head of Chemical Process Development2013 — 2014New York City Metropolitan Area
  12. Forest Laboratories (now Allergan)Associate Director, Chemical Process Development2012 — 2013
  13. Forest Laboratories (now Allergan)Assistant Director, Chemical Process Development2009 — 2011
  14. Forest Laboratories (now Allergan)Principal Investigator, Medicinal Chemistry2006 — 2008
  15. Forest Laboratories (now Allergan)Senior Research Scientist, Medicinal Chemistry2005 — 2006
  16. Forest Laboratories (now Allergan)Research Scientist I, Medicinal Chemistry2004 — 2005
  17. Albany Molecular ResearchSenior Research Scientist I2002 — 2004
  18. BayerAnalytical Method Development1995 — 1998

Skills & more

ChemistryAPI DevelopmentCMC developmentDrug DiscoveryPharmaceutical IndustryDrug DevelopmentChemical Process DevelopmentAnalytical ChemistryHPLCTechnology TransferChromatographyGLP
+12 moreLifesciencesCROClinical DevelopmentBiotechnologyFDAChemical ProcessingGMPProject ManagementManagementOrganic ChemistryLife SciencesMedicinal Chemistry

From Matthew's professional profile.

Frequently asked questions

Who is Matthew D. Ronsheim?
Chief Operating Officer at Xenon Pharma
Where does Matthew D. Ronsheim work?
Matthew D. Ronsheim is Chief Operating Officer at Xenon Pharma.
Where did Matthew D. Ronsheim go to school?
Matthew D. Ronsheim studied at University of New Hampshire (Ph.D., Chemistry).

Same school

Also attended University of New Hampshire71

Jessica DowdInvestor at OpenView Venture PartnersRosemary SullivanOperations Manager at RET VenturesAndrew BrochuController at Castle Island VenturesBryce BlairAdvisory Board at Navitas CapitalChris StoneInvestor at EPIC VENTURESDillon HealyHead of Business Development & Capital Formation, North America at Sora Ventures

+ 65 more

Shared employers

Also worked at Enanta Pharmaceuticals4

Dr. Jens EcksteinAdvisor at Apollo Health VenturesAxel BolteFounder at Inozyme PharmaTara L. KiefferChief Product Strategy Officer at Enanta PharmaceuticalsBrendan LuuChief Business Officer at Enanta Pharmaceuticals

Also worked at Merck181

Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesUri LopatinInvestor at Khosla Ventures

+ 175 more

Also worked at Cubist Pharmaceuticals9

Courtney TurnerDirector of Finance at Cure VenturesGil AddoOperating Partner at Waterline VenturesMark CarthyInvestor at Walnut Venture AssociatesCasey DouganPartner & SVP Operations at Ajax HealthClare FisherSenior Vice President, Business Development and Mergers & Acquisitions at BeiGeneRyan WetzelCo-founder & Head of Operations at iink

+ 3 more

Also worked at Forest Laboratories (now Allergan)12

Jayson RiegerManaging Partner at PBM CapitalJeffrey M. JonasPartner at Cure VenturesJulia StephanusPartner at Borealis VenturesIvan GergelManaging Partner and Chief Medical Officer at New Rhein Healthcare Investors, LLCStephen LePartner at MBK PartnersKristen RooneyHead of Business Development at Third Prime

+ 6 more